GoodRx Holdings (GDRX) Long-Term Investments (2020)

GoodRx Holdings (GDRX) reported Long-Term Investments of $711.4 million for Q4 2020.

GoodRx Holdings (GDRX) Long-Term Investments (2020) Analysis & Trends

GoodRx Holdings (GDRX) has 1 years of Long-Term Investments data on file, last reported at $711.4 million in Q4 2020.

  • For the quarter ending Q4 2020, Long-Term Investments changed N/A year-over-year to $711.4 million; the trailing twelve-month figure through Dec 2020 stood at $711.4 million (changed N/A YoY), and the FY2020 full-year result was $711.4 million, changed N/A from the prior year.
  • Long-Term Investments held at $711.4 million in Q4 2020.
  • In the past five years, Long-Term Investments ranged from a high of $711.4 million in Q4 2020 to a low of $711.4 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn -
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 7.49 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn -
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn -
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn 89.77 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn -
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn -
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn -
9 Privia Health 3.10 Bn 2.73 Bn - -
10 GoodRx Holdings 977.32 Mn 741.61 Mn 173.85 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 711.38 Mn